Clinical Trials · NCT00066807
Premenopausal Endocrine Responsive Chemotherapy Trial
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- ETOP IBCSG Partners Foundation
- Enrollment
- 29
- Start date
- Aug 2003
- Locations
- 6 sites, 3 countries
- Primary endpoint
- Disease-free Survival